Literature DB >> 2462154

Cloning, expression and characterization of the 36 KDal Salmonella typhi porin gene in Escherichia coli.

J Agüero1, G Mora, M J Mroczenski-Wildey, M E Fernandez-Beros, L Aron, F C Cabello.   

Abstract

A recombinant plasmid containing the gene for the 36 KDal porin of Salmonella typhi has been identified in a cosmid library of S. typhi propagated in Escherichia coli. The recombinant clone was identified by its ability to endow E. coli with susceptibility to porin specific phages, and by the appearance in the outer membrane of E. coli containing the clone of a new protein of 36 KDal. While the porin confers upon a porinless mutant of E. coli an increased susceptibility to beta-lactam antibiotics, it does not react with serum from patients with typhoid fever in immunoblotting assays.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2462154     DOI: 10.1016/0882-4010(87)90010-6

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  10 in total

1.  Primary structure of the porin protein of Haemophilus influenzae type b determined by nucleotide sequence analysis.

Authors:  E J Hansen; C Hasemann; A Clausell; J D Capra; K Orth; C R Moomaw; C A Slaughter; J L Latimer; E E Miller
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

2.  A Salmonella typhi OmpC fusion protein expressing the CD154 Trp140-Ser149 amino acid strand binds CD40 and activates a lymphoma B-cell line.

Authors:  Mario I Vega; Leopoldo Santos-Argumedo; Sara Huerta-Yepez; Rosendo Luría-Perez; Vianney Ortiz-Navarrete; Armado Isibasi; Cesar R González-Bonilla
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

3.  Salmonella typhi O:9,12 polysaccharide-protein conjugates: characterization and immunoreactivity with pooled and individual normal human sera, sera from patients with paratyphoid A and B and typhoid fever, and animal sera.

Authors:  L Aron; J Di Fabio; F C Cabello
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

4.  Clinical isolate of a porinless Salmonella typhi resistant to high levels of chloramphenicol.

Authors:  C S Toro; S R Lobos; I Calderón; M Rodríguez; G C Mora
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

5.  Epidemic typhoid in Chile: analysis by molecular and conventional methods of Salmonella typhi strain diversity in epidemic (1977 and 1981) and nonepidemic (1990) years.

Authors:  A E Fica; S Prat-Miranda; A Fernandez-Ricci; K D'Ottone; F C Cabello
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

6.  Effect of external pH perturbations on in vivo protein synthesis by the acidophilic bacterium Thiobacillus ferrooxidans.

Authors:  A M Amaro; D Chamorro; M Seeger; R Arredondo; I Peirano; C A Jerez
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

7.  Further consideration of the clonal nature of Salmonella typhi: evaluation of molecular and clinical characteristics of strains from Indonesia and Peru.

Authors:  A Franco; C Gonzalez; O S Levine; R Lagos; R H Hall; S L Hoffman; M A Moechtar; E Gotuzzo; M M Levine; D M Hone
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

8.  Salmonella-specific monoclonal antibodies against recombinant Salmonella typhi 36-kilodalton porin.

Authors:  V Kissel; C Gonzalez; M Astudillo; A Godard; B Wachman; F C Cabello
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

9.  A porin from Klebsiella pneumoniae: sequence homology, three-dimensional model, and complement binding.

Authors:  S Albertí; F Rodríquez-Quiñones; T Schirmer; G Rummel; J M Tomás; J P Rosenbusch; V J Benedí
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

10.  Chromosomal DNA, iron-transport systems, outer membrane proteins, and enterotoxin (heat labile) production in Salmonella typhi strains.

Authors:  G Faundez; L Aron; F C Cabello
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.